Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
270.21+3.64 (+1.37%)
At close: 4:00PM EDT
| Previous close | 266.57 |
| Open | 266.30 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 266.29 - 271.91 |
| 52-week range | 223.25 - 468.55 |
| Volume | 1,374,221 |
| Avg. volume | 992,016 |
| Market cap | 40.681B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 14.01 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Biogen inc (BIIB) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool. Biogen inc (NASDAQ: BIIB)Q3 2021 Earnings CallOct 20, 2021, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning.
- Zacks
Biotech Stock Roundup: BIIB's Q3 Earnings, REGN's COVID-19 Cocktail Update & More
Regulatory and pipeline updates from bigwigs like Regeneron (REGN) and Biogen (BIIB) have been the biotech sector's few key highlights during the past week.
© 2021 Verizon Media. All rights reserved.
